| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.05 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | -0.28 | 0.05 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.05 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.073 | 0.05 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.05 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.05 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | -0.067 | 0.05 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.05 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.056 | 0.05 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | 0.067 | 0.05 |